Portugal

BMI View: With hospital debt levels rising and payment times getting longer, we believe the Portuguese public hospital sector will remain a significant drag on pharmaceutical companies... 2012-03-27

BMI Core View: The uptake of generic drugs following patent expiries will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies,... 2010-05-25

BMI Core View: The introduction of government price erosion mechanisms will accelerate across Europe. This view is supported by need for fiscal austerity and the actions of numerous... 2010-05-24

High levels of Portuguese government debt have filtered through to the healthcare sector, with public hospitals owing the pharmaceutical industry around EUR625mn (US$856mn) in 2009.... 2010-02-08

Spanish drugmaker Faes Farma has signed an agreement with Laboratorios Cinfa for the joint marketing and distribution of generic drugs in Portugal. BMI commends the focus of the partnership... 2009-11-25

The consumption of sedatives and antidepressants in Portugal is on the rise, according to the country's National Health Plan. Depression is significant problem for society, with its... 2009-08-03

BMI's Drug Expenditure Forecast Model for Portugal has been indirectly validated by figures revealed by the Portuguese Association of the Pharmaceutical Industry (APIFARMA). On January... 2009-04-02

The European Commission (EC) has made a formal request that Germany and Portugal review their laws on the ownership of pharmacies. The requests - which take the form of Reasoned Opinions... 2008-09-26

In-line with legislation that came into effect during 2007, as of April 1 2008, certain groups of drugs will become subject to price reductions in Portugal. The Portuguese government... 2008-04-04

Under reforms to the Medicines Law approved in May 2006, Portuguese pharmaceutical distributors will be able to obtain any 'equivalent' foreign medicines that are priced lower than... 2006-09-01